Health Sciences & Medicine
Pages 8 (2008 words)
Download 0
There are several elements that will be discussed here with regard to specific standards of practice and this would deal with the Vitamin K administration to babies. Here I would critically analyse the research, clinical guidelines and policy bases of vitamin K administration and use the extent and thoroughness of evidence to evaluate the truth or veracity of the arguments.


Vitamin K (Phylloquinone) is known as the clotting vitamin as blood would not clot without it. Bruising and excess bleeding would be common symptoms of Vitamin K deficiency as blood clotting would take longer time than usual with deficiency in the vitamin (Bay et al, 2006; DoH, 1998). Specific recommendations of doses of vitamin K may vary according to age, gender and even conditions of health. This essay is however specifically on the application of vitamin K to babies orally or through intravenous means to prevent VKDB in newborns.
Vitamin K deficiency causes a bleeding condition which is known as the hemorrhagic disease of the newborn or HDN and this can occur anytime between the first months of being born (Puckett and Offringa, 2007). Puckett and Offringa (2007) divided hemorrhagic disease of the newborn into three categories of early, classic and late HDN with early HDN occurring within 24 hours, classic HDN occurring between 1 to 7 days and late HDN occurring between 2 to 12 weeks with intracranial, cutaneous or gastrointestinal bleeding.
Bleeding in the newborn can be through gums, nose or gastrointestinal tract especially in babies who had complicated delivery including breech delivery and the risks increase when ...
Download paper
Not exactly what you need?